Purpose of the review
Recent studies in the kidney have revealed that the well-characterized tumor antigen mucin 1 (MUC1/Muc1) also has numerous functions in the normal and injured kidney.
Recent findings
Mucin 1 is a transmembrane mucin with a robust glycan-dependent apical targeting signal and efficient recycling from endosomes. It was recently reported that the TRPV5 calcium channel is stabilized on the cell surface by galectin-dependent cross-linking to mucin 1, providing a novel mechanism for regulation of ion channels and normal electrolyte balance.
Our recent studies in mice show that mucin 1 is induced after ischemia, stabilizing HIF-1α and β-catenin levels, and transactivating the HIF-1 and β-catenin protective pathways. However, prolonged induction of either pathway in the injured kidney can proceed from apparent full recovery to chronic kidney disease. A very recent report indicates that aberrant activation of mucin1 signaling after ischemic injury in mice and humans is associated with development of chronic kidney disease and fibrosis. A frame-shift mutation in MUC1 was recently identified as the genetic lesion causing Medullary Cystic Kidney Disease type 1, now appropriately renamed MUC1 Kidney Disease (MKD).
Summary
Studies of mucin 1 in the kidney now reveal significant functions for the extracellular mucin-like domain and signaling through the cytoplasmic tail.